The same nine — now twelve — hallmarks that drive systemic ageing play out in skin with unusual visibility. Understanding them explains why some interventions work and most don't.
Skin is the only organ whose ageing you can watch in real time. The wrinkle forming at the corner of your eye, the loss of elasticity you notice when you pinch the back of your hand, the gradual thinning of the dermis — these are not cosmetic inconveniences. They are the visible expression of the same molecular processes that are ageing your heart, your brain, and your immune system. The difference is that in skin, you can see them.
The hallmarks of ageing framework, first published by López-Otín and colleagues in Cell in 2013 and updated in 2023, provides the most useful map of these processes. Not all twelve hallmarks are equally visible in skin, but most of them leave a traceable mark.
DNA damage foci — marked by γH2AX, a histone modification that signals double-strand breaks — increase exponentially with age in dermal fibroblasts. Ultraviolet radiation is the dominant extrinsic driver: UVB creates cyclobutane pyrimidine dimers (CPDs) in DNA directly; UVA generates reactive oxygen species (ROS) that damage DNA indirectly. Photoaging accounts for approximately 80% of extrinsic skin ageing. The remaining 20% is intrinsic — driven by replication errors, mitochondrial ROS, and the gradual failure of DNA repair machinery.
Keratinocytes — the cells that form the outer layers of skin — divide continuously throughout life. Each division shortens telomeres slightly. When telomeres reach a critical length, the cell enters senescence or apoptosis. Telomere length in skin correlates with chronological age, and shorter telomeres are associated with impaired wound healing and reduced barrier function. The connection to cancer is also direct: over 90% of squamous cell carcinomas exhibit active telomerase, suggesting that telomere-driven senescence is a tumour-suppression mechanism that the cancer cell must circumvent.
The Horvath epigenetic clock — a methylation-based measure of biological age — was originally calibrated on skin and blood. In skin specifically, p16INK4a expression (a marker of epigenetic senescence) directly correlates with chronological age in vivo. Epigenetic drift in skin fibroblasts leads to altered gene expression patterns: reduced collagen synthesis, increased MMP (matrix metalloproteinase) activity, and impaired response to growth factors. These changes are not caused by DNA sequence mutations; they are changes in how the genome is read.
Senescent cells accumulate in aged skin. They do not divide, but they are metabolically active — secreting a cocktail of pro-inflammatory cytokines, chemokines, and proteases collectively called the senescence-associated secretory phenotype (SASP). In the dermis, SASP-secreting fibroblasts degrade the extracellular matrix, recruit immune cells, and create a chronic low-grade inflammatory environment. p16INK4a-positive senescent cells are directly visible in aged human skin biopsies and increase with both chronological age and UV exposure.
p16INK4a expression directly correlates with chronological aging of human skin in vivo. Senescent cells are not passive bystanders — they actively remodel the dermal environment through SASP.
— Orioli & Dellambra, Cells, 2018
Inflammaging — the chronic, low-grade systemic inflammation that characterises aged organisms — has a particularly visible expression in skin. IL-1β, IL-6, and TNF-α levels rise in aged dermis. NF-κB, the master regulator of inflammatory gene expression, becomes constitutively active. The result is a feed-forward loop: inflammation drives MMP activation, which degrades collagen and elastin, which impairs barrier function, which allows more inflammatory triggers to enter. The loop is self-sustaining.
Collagen type I is the primary structural protein of the dermis. Its synthesis declines approximately 1% per year after age 25. Simultaneously, MMP-1 (collagenase) and MMP-3 (stromelysin) activity increases with both age and UV exposure — MMP-1 gene expression increases more than fourfold in keratinocytes after UVB treatment. The net result is a progressive loss of dermal collagen density that is measurable by ultrasound and visible as skin laxity.
The hallmarks framework makes it possible to evaluate skin interventions rationally. Sunscreen addresses genomic instability (by reducing UV-induced DNA damage) and is the single most evidence-supported anti-ageing skin intervention available. Retinoids address epigenetic alterations and loss of proteostasis (by upregulating collagen synthesis and downregulating MMP activity). Senolytics — compounds that selectively eliminate senescent cells — are in early human trials for skin applications. NAD+ precursors support DNA repair machinery. Spermidine induces autophagy, which clears damaged proteins and organelles.
Editorial position
Skin ageing is systemic ageing made visible. The interventions with the strongest evidence — UV protection, retinoids, adequate sleep, exercise — address multiple hallmarks simultaneously. Single-target supplements address one hallmark at best. The most rational approach combines broad lifestyle interventions with targeted compounds where the evidence is strong.
Collagen supplements: which forms are absorbed and which are not
Not all collagen is equal. The difference between a product that works and one that doesn't comes down to molecular weight, peptide composition, and what happens in the gut before any of it reaches your skin.
Does oral hyaluronic acid actually reach the skin?
Sceptics said it couldn't survive the gut. The 2026 RCT in 150 people says it does — and the effect on skin hydration is measurable. Here is what the trial actually showed.
The UV damage cascade: how sun exposure ages skin at the molecular level
Photoaging accounts for 80% of extrinsic skin ageing. Understanding the molecular cascade — from photon to wrinkle — explains why sunscreen is the most evidence-supported anti-ageing intervention available.
Astaxanthin vs vitamin C for skin: a head-to-head evidence review
Both are antioxidants. Both have RCT evidence for skin outcomes. But they work through different mechanisms, target different problems, and the evidence for each is stronger in different areas.